implantable drug delivery devices market n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Implantable Drug Delivery Devices Market is Expected to Reach US$ 27 Billion by 2021 PowerPoint Presentation
Download Presentation
Implantable Drug Delivery Devices Market is Expected to Reach US$ 27 Billion by 2021

Loading in 2 Seconds...

play fullscreen
1 / 4

Implantable Drug Delivery Devices Market is Expected to Reach US$ 27 Billion by 2021 - PowerPoint PPT Presentation


  • 2 Views
  • Uploaded on

The implantable drug delivery devices market is expected to exceed more than US$ 27 billion by 2021; Growing at a CAGR of more than 8.6% in the given forecast period.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Implantable Drug Delivery Devices Market is Expected to Reach US$ 27 Billion by 2021' - danishsmith01


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
implantable drug delivery devices market

Implantable Drug Delivery Devices Market is Expected to Reach US$ 27 Billion by2021

Market Research Engine has published a new report titled as “Implantable Drug Delivery Devices Market by Applications, by Product Types and by Technology - Global Market Analysis and Forecast 2016 -2021”

The implantable drug delivery devices market is expected to exceed more than US$ 27 billion by 2021; Growing at a CAGR of more than 8.6% in the given forecastperiod.

Implantable devices having many functions such as it vascular stents preserve flow of blood. The electro-stimulation devices control heart block spurious in the brain. Implantable drug delivery devices permit site specific drug management where that drug requires more. There has been rising union between drug therapies and implantable devices such as devices that carry drugs as primeaction.

The major driving factors of implantable drug delivery devices market are as follows:

Driving factors for the global contraceptive drug delivery implants market NGO and government initiatives to support contraceptive goods Increasing frequency of unwantedpregnancies

Driving factors for the global intraocular drug delivery implantsmarket

Increasing patient group for diabetic retinopathy and diabetes Growing aging populationglobally

Driving factors for the global implantable drug infusion pumps market High predominance of chronic pain causingdisorders

Increasing frequency of colorectal cancer globally Driving factors for the global brachytherapy seedsmarket

Appearance of new disease appliances Growing prevalence of prostate cancerglobally

Driving factors for the global coronary stents Increasing many interventional cardiologists Rising frequency of cardiovasculardiseases

Browse Full Report: https://www.marketresearchengine.com/reportdetails/implantable- drug-delivery-devices-market

The restraining factors of implantable drug delivery devices market are asfollows:

Strict CE and FDA approvalnorms.

The introduction of internal product substitutes, lawsuits and productrecalls.

the implantable drug delivery devices market

The implantable drug delivery devices market is segmented on the lines of its product type, technology, application and regional. Based on product type segmentation it covers implantable drug infusion pumps, implantable brachytherapy seeds, implantable intraocular drug delivery devices, implantable contraceptive drug delivery devices, implantable bio absorbable stents and implantable coronary drug eluting stents. Under technology segmentation the implantable drug delivery devices market contains non biodegradable implantable drug delivery device technology and biodegradable implantable drug delivery device technology. The implantable drug delivery devices market is segmented on the lines of its application like oncology, birth control/ contraception, cardiovascular, ophthalmology and others such as chronic pain causing diseases and diabetes. The implantable drug delivery devices markets geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCCcountries.

This reportprovides:

An overview of the global market for implantable drug delivery devices and related technologies.

Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through2021.

Identifications of new market opportunities and targeted promotional plans for implantable drug deliverydevices.

Discussion of research and development, and the demand for new products and new applications.

Comprehensive company profiles of major players in theindustry.

REPORTSCOPE:

The scope of the report includes a detailed study of global and regional markets for Implantable drug delivery devices with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market, current market trends and situations. Key players profiled in the report include Allergan Inc, Bayer HealthCare, Medtronic Inc., Nucletron, Merck, pSivida Corp., Boston Scientific Corporation, Abbott Laboratories and Bausch and Lomb Inc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

Sample Report: https://www.marketresearchengine.com/reportdetails/implantable-drug- delivery-devices-market

the implantable drug delivery devices market 1

The Implantable drug delivery devices Markethas been segmented asbelow:

By Product TypeAnalysis

Implantable drug infusion pumps Implantable brachytherapy seeds Implantable intraocular drug deliverydevices

Implantable contraceptive drug delivery devices Implantable bio absorbablestents

Implantable coronary drug elutingstents

By Technology Analysis

Non biodegradable implantable drug delivery device technology Biodegradable implantable drug delivery devicetechnology

By ApplicationAnalysis

Oncology

Birth control/ contraception Cardiovascular Ophthalmology

Other (chronic pain causing diseases,diabetes)

By RegionalAnalysis

NorthAmerica Europe

Asia-Pacific

Rest of theWorld

Table ofContents

Chapter 1Preface

Chapter 2 Executive Summary Chapter 3 MarketOverview

Chapter 4 Implantable Drug Delivery Devices Market, By Product Types Chapter 5 Global Implantable Drug Delivery Devices Market, By Technology Chapter 6 Global Implantable Drug Delivery Devices Market, By Applications Chapter 7 Implantable Drug Delivery Devices Market ByGeography

chapter 8 recommendations chapter 9 competitive

Chapter 8Recommendations

  • Chapter 9 Competitive Landscape Chapter 10 CompanyProfiles
    • Merck
    • Bausch & LombInc.
    • MedtronicInc.
    • Allergan,Inc.
    • Psivida Corp.
    • BayerHealthcare
    • Nucletron
    • Boston ScientificCorporation
    • Abbott Laboratories

MediaContact

Company Name: Market ResearchEngine

Contact Person: JohnBay

Email:john@marketresearchengine.com

Phone: +1-855-984-1862

Country: UnitedStates

Website:https://www.marketresearchengine.com/